Environmental protection

Managing our environmental impact across all our activities and products, working toward a restorative approach


Highlights


62%

of our total electricity use is sourced or generated from renewable sources

CDP A lists

for Water Security and Climate Change for the fourth consecutive year, for our actions and disclosures on climate change and water stewardship

$15.5 million

invested in environmental efficiency projects (NRRGG Fund)


97%

of active pharmaceutical ingredient (API) discharges from suppliers demonstrated as safe [1]

18%

reduction in our water use since 2015

44%

of recycling as total waste



Our approach

Climate change is now a climate crisis. It is impacting human health and the biosphere in increasingly severe ways. We are taking action now because we recognise the strong connection between a healthy planet and healthy people. With health at the heart of our business, we work to foster environments in which all life can thrive - seeking opportunities for environmental stewardship and mitigating climate impacts by managing natural resources and ensuring environmental safety of our products across our operations and value chain. We envision a future where we help restore our planet to health by achieving zero carbon emissions.


Our Environmental Protection focus areas include:



Our Environmental protection approach supports the following Sustainable Development Goals (SDGs)




Our stories





Read more about Environmental protection in our Sustainability Report.

To view our policies, standards and positions, visit our Resources page.



Environmental risk data relating to our medicines

Here you can find an overview of the environmental risk of AstraZeneca’s medicines. This information will be updated, if appropriate, as new data becomes available. See Environmental risk data relating to our medicines


References

1. Scope is 47 APIs for which data is available to calculate safe API discharge limits and based on 2018 manufacture.